2-arylbenzimidazoles as PPARGC1A activators for treating neurodegenerative diseases
US10851066B2 · kind B2 · utility
1Cited by
7References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 29, 2020 |
| Grant date | Dec 1, 2020 |
| Priority date | — |
| Expiry date | May 29, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The compound 2-(3-tert-Butylphenyl)-4,6-difluoro-1H-benzo[d]imidazole and its use are disclosed: The compound activates Ppargc1a and, as a consequence, is useful for treating neuroinflammation and for treating a variety of neurodegenerative diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.